Companies / TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc.
Nasdaq: TLSICIK 1826667WESTMINSTER, CO
Financials · FY2025
Ownership
61.6M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 7.16% | 4,410,003 |
| Institutions | 22.65% | 13,945,532 |
| Public float | 70.19% | 43,219,065 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Matlin David JDirector | 2.15% | 1,323,210 |
Stansky Michael PDirector | 1.60% | 986,830 |
Szela Mary TCEOCEO and President · Director | 1.22% | 752,987 |
Hicks Kerry RDirector | 0.88% | 542,790 |
Patience DavidChief Financial Officer | 0.44% | 268,657 |
Cox Bryan F.Chief of Research | 0.27% | 163,415 |
Stevens JenniferChief Regulatory Officer | 0.20% | 124,110 |
Marshak RichardChief Commercial Officer | 0.18% | 110,397 |
Devlin JodiChief of Clinical Operations | 0.16% | 97,364 |
Valle WilliamDirector | 0.05% | 30,487 |
Institutional holders 71
View all →| Holder | Value | % of shares |
|---|---|---|
| $14.45M | 3.36% | |
| $12.10M | 4.32% | |
| $10.68M | 2.49% | |
| $8.68M | 2.02% | |
| $6.83M | 1.59% | |
| $4.49M | 1.05% | |
| $3.11M | 1.26% | |
| $2.84M | 0.66% | |
| $2.78M | 0.99% | |
| $2.55M | 0.59% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $5.12M | +1.1M +73.31% | 2,659,218 4.32% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $1.58M | +346K +130.88% | 610,963 0.99% of shares | low |
| Q1 2026 as of | Apis Capital Advisors, LLC 13F manager | New | Common stock | $720.0K | +180K | 180,000 0.29% of shares | low |
| Q1 2026 as of | White Pine Capital LLC 13F manager | Add | Common stock | $421.0K | +105K +179.77% | 163,810 0.27% of shares | low |
| Q1 2026 as of | Intrust Bank NA 13F manager | New | Common stock | $264.0K | +66K | 66,000 0.11% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Exit | Common stock | $-249.0K | -36K -100.00% | 0 | low |
| Q1 2026 as of | Formula Growth Ltd 13F manager | New | Common stock | $200.0K | +50K | 50,000 0.08% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $163.0K | +30K +93453.13% | 29,937 0.05% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| James J. Pallotta | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TLSI | — | 89680M101 |